93005 ⎘
Compounds containing nitrogen atoms doubly-bound to a carbon skeleton; Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
#2ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS
#3STYRYL CARBOXYLATE DERIVATIVES
#4MATERIALS AND METHODS FOR IODINE CAPTURE
#5STYRYL CARBOXYLATE DERIVATIVES
#6ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS
#7Analogs of Nitrofuran Antibiotics to Combat Resistance
#8Alkoxy compounds for disease treatment
#9Anti-fungals compounds targeting the synthesis of fungal sphingolipids
#10ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
#11Styryl carboxylate derivatives
#12USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
#13Analogs of Nitrofuran Antibiotics to Combat Resistance
#14PARG inhibitors and method of use thereof
#15ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR
#16COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
#17KINASE INHIBITOR
#18Method for detecting copper(II) ions using a hydrazone-based colorimetric sensor
#19Alkoxy compounds for disease treatment
#20Compounds with antimicrobial activity
#21Composition for detecting acidic compound
#22Organ preconditioning formulation with mitochondrial elongating agents
#23Anti-fungals compounds targeting the synthesis of fungal sphingolipids
#24ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME
#252-amino-N'-benzylideneacetohydrazides and derivatives for the management of CFTR protein mediated diseases
#26Anti-fungals targeting the synthesis of fungal shingolipids
#27Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound
#28Photochromic hydrazone switches
#29Alkoxy compounds for disease treatment
#30Multi-directional polydentate ligands for metal-organic hybrid structures
#31Metal-organic hybrid structures built with multi-directional polydentate ligands
#32Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound
#33Aromatic compounds from furanics
#34Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof
#35Polymerizable compound and optically anisotropic body
#36Polymerizable compound and optically anisotropic body
#37Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#38Alkoxy compounds for disease treatment
#392-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR protein mediated diseases
#40ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
#41Substituted acethydrazide derivative, preparation method and use thereof
#42PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS
#43Polymerizable compound, polymerizable composition, polymer, and optically anisotropic product
#44Bishydrazone-based antifungal agents
#45Polymerizable compound and optically anisotropic body
#46Polymerizable compound and optically anisotropic object
#47Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance
#48Polymerizable compound and optically anisotropic body
#49A Substituted Acethydrazide Derivative, Preparation Method and Use Thereof
#50Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
#51Alkoxy compounds for disease treatment
#52Polymerizable compound, polymerizable composition, polymer, and optically anisotropic product
#53Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound
#54Polymerizable compound, polymerizable composition, polymer, and optically anisotropic product
#55Degradable hydrazone curing agents and applications thereof
#56Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#57Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material
#58Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
#59Compositions and methods for the treatment of inflammatory bowel disease
#60Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance
#61Hematopoietic growth factor mimetic small molecule compounds and their uses
#62Alkoxy compounds for disease treatment
#63Anti-proliferative compounds and uses thereof
#64Reaction product of hydrazine derivatives and carbon dioxide
#65Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#66TCR/MHCII-collagen interaction inhibitors useful for treatment of rheumatoid arthritis
#67BISPHENOL ETHER COMPOUNDS WITH NOVEL BRIDGING GROUPS AND METHODS FOR THEIR USE
#68Androgen receptor ligands
#69PREPARATION OF HALOALKOXYARYLHYDRAZINES AND INTERMEDIATES THEREFROM
#70Tumor necrosis factor inhibitors
#71Intermediate for manufacture of polymerizable compound and process for manufacture thereof
#72Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
#73Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body
#74Synthesis and analysis of compounds capable of inducing differentiation of human mesenchymal stems cells into hepatocytes
#75Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus
#76PDE10 inhibitors and related compositions and methods
#77Resin, optical material, and optical device
#78Deacetylase inhibitors and uses thereof
#79Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
#80Alkoxy compounds for disease treatment
#81TARGETED CORRECTION OF A GENETIC DEFECT IN CANCER THERAPY
#82Tumor necrosis factor inhibitors
#83Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus
#84Compound, charge transporting film, photoelectric conversion device, and electrophotographic photoreceptor using the compound, method of producing electrophotographic photoreceptor, process cartridge, and image forming apparatus
#85Compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor, process cartridge, and image forming apparatus
#86Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#87Hematopoietic growth factor mimetic small molecule compounds and their uses
#88Enhancers of protein degradation
#89Gain-of-function Bcl-2 inhibitors
#90Alkoxy compounds for disease treatment
#91Targeting NAD biosynthesis in bacterial pathogens
#92Phenolic hydrazone macrophage migration inhibitory factor inhibitors
#93Compounds for the inhibition of herpes viruses
#94Antiviral drugs for treatment of arenavirus infection
#95Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
#96FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER
#97FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER
#98Alkoxy compounds for disease treatment
#99Alkoxy compounds for disease treatment
#100COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
#101Fungicidal compositions including hydrazone derivatives and copper
#102Non-steroidal compounds
#103Fungicidal compositions including hydrazone derivatives and copper
#104Fungicidal compositions including hydrazone derivatives and copper
#105SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER
#106Fungicidal compositions including hydrazone derivatives and copper
#107Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#108Method for preparing 1,3,4-substituted pyrazol compounds
#109Deacetylase inhibitors and uses thereof
#110Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS
#111Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#112Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#113Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#114SPECIFIC INHIBITORS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
#115Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives
#116Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
#117Methods for treating a variety of diseases and conditions, and compounds useful therefor
#118Compounds
#119Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#120Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#121Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
#122NOVEL FORMYL PEPTIDE RECEPTOR LIKE 1 AGONISTS THAT INDUCE MACROPHAGE TUMOR NECROSIS FACTOR ALPHA AND COMPUTATIONAL STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF THEREOF
#123PDE10 inhibitors and related compositions and methods
#124Alkoxy compounds for disease treatment
#125Ligands for estrogen related receptors and methods for synthesis of said ligands
#126OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS
#127Tumor necrosis factor inhibitors
#128Methods of identifying neuroprotective compounds for retinal ganglion cells
#129Phenolic hydrazone macrophage migration inhibitory factor inhibitors
#130Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#131Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#132Inhibitors of Transthyretin Amyloid Fibril Formation
#133Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
#134Antiviral drugs for treatment of arenavirus infection
#135Chemokine receptor modulators
#136Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
#137Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#138Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#139Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
#140ACYLHYDRAZONE DERIVATIVES AND THE USE THEREOF IN THE INHIBITION, REGULATION AND/OR MODULATION OF KINASE SIGNAL TRANSDUCTION
#141Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#142Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents
#143Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#144Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#145Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
#146Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#147Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#148Fc receptor modulating compounds and compositions
#149Specific inhibitors for vascular endothelial growth factor receptors
#150Ligands for metals and improved metal-catalyzed processes based thereon
#151Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides
#152Process for producing hydrazone compound
#153Method of forming a carbon-heteroatom bond
#154Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
#155Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
#156Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
#157Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction
#158Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
#159Hydrazone derivative
#160Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds
#161Fc receptor modulating compounds and compositions
#162Derivatization of non-natural amino acids and polypeptides
#163Compound inhibiting in vivo phosphorous transport and medicine containing the same
#164Therapies using non-natural amino acids and polypeptides
#165Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#166Ligands for estrogen related receptors and methods for synthesis of said ligands
#167Inhibitors of transthyretin amyloid fibril formation
#168Methods for treating neural disorders and conditions, and compounds useful therefor
#169Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
#170Linked dihydrazone-based charge transport compounds
#171Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#172Ligands for metals and improved metal-catalyzed processes based thereon
#173Hydrazone compound, electrophotographic photoreceptor comprising the hydrazone compound, and image forming apparatus equipped with the electrophotographic photoreceptor
#174Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
#175Beta-secretase inhibitors
#176Hydrazone-based charge transport materials
#177Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
#178Inhibitors of HCV NS5B polymerase
#179Organophotoreceptor with a charge transport material having at least three linked hydrazone groups
#180Process for the preparation of aryl hydrazone and aryl hydrazine